novo nordisk semaglutide vial Nordisk's shows promise in Phase III CKD trial Novo Nordisk's semaglutide shortage officially

GLP-1 receptor agonists bring a range of benefits for people managing type 2 diabetes alongside chronic kidney disease (CKD)

it does not cure behavioral eating disorders

Dehydration Risks with Ozempic: Worsening Side Effects: Dehydration can worsen symptoms like nausea, fatigue, and headaches often experienced when starting Ozempic [2]

GLP-1 has a variety of physiological functions, which can regulate blood glucose level by promoting insulin secretion and synthesis, stimulating -cell proliferation and inducing islet regeneration, inhibiting -cell apoptosis and glucagon release, delaying gastric emptying and controlling appetite (Mller et al., 2019